Trial intelligence / Profile preview

ADAPT trial of intracoronary adenosine during primary PCI for acute myocardial infarction

NL-OMON22898Active, not recruiting

Sponsor: University Medical Center Groningen
Start: Aug 2007
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries: 1

Overview

Randomised, single-blind trial in myocardial infarction (MI) comparing Intracoronary adenosine with Placebo (2 arms). Primary endpoint: Residual ST-segment deviation at 30 to 60 minutes after the procedure. Started Aug 2007; status: active, not recruiting.

Drugs

adenosine

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NL-OMON22898.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON22898.